Division of Human Genetics, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Sickle Cell Programme, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.
OMICS. 2020 Oct;24(10):559-567. doi: 10.1089/omi.2020.0153.
Sickle cell disease (SCD) is one of the most common blood disorders impacting planetary health. Over 300,000 newborns are diagnosed with SCD each year globally, with an increasing trend. The sickle cell disease ontology (SCDO) is the most comprehensive multidisciplinary SCD knowledge portal. The SCDO was collaboratively developed by the SCDO working group, which includes experts in SCD and data standards from across the globe. This expert review presents highlights and lessons learned from the fourth SCDO workshop that marked the beginning of applications toward planetary health impact, and with an eye to empower and cultivate multisite SCD collaborative research. The workshop was organized by the Sickle Africa Data Coordinating Center (SADaCC) and attended by 44 participants from 14 countries, with 2 participants connecting remotely. Notably, from the standpoint of democratizing and innovating scientific meeting design, an SCD patient advocate also presented at the workshop, giving a broader real-life perspective on patients' aspirations, needs, and challenges. A major component of the workshop was new approaches to harness SCDO to harmonize data elements used by different studies. This was facilitated by a web-based platform onto which participants uploaded data elements from previous or ongoing SCD-relevant research studies before the workshop, making multisite collaborative research studies based on existing SCD data possible, including multisite cohort, SCD global clinical trials, and SCD community engagement approaches. Trainees presented proposals for systematic literature reviews in key SCD research areas. This expert review emphasizes potential and prospects of SCDO-enabled data standards and harmonization to facilitate large-scale global SCD collaborative initiatives. As the fields of public and global health continue to broaden toward planetary health, the SCDO is well poised to play a prominent role to decipher SCD pathophysiology further, and co-design diagnostics and therapeutics innovation in the field.
镰状细胞病(SCD)是影响全球健康的最常见血液疾病之一。每年在全球范围内有超过 30 万新生儿被诊断患有 SCD,且呈上升趋势。镰状细胞病本体论(SCDO)是最全面的多学科 SCD 知识库。SCDO 是由 SCDO 工作组共同开发的,该工作组包括来自全球的 SCD 专家和数据标准专家。本次专家综述介绍了第四届 SCDO 研讨会的重点内容和经验教训,该研讨会标志着 SCDO 开始向行星健康影响领域的应用迈进,并着眼于赋予和培养多站点 SCD 合作研究的能力。该研讨会由 Sickle Africa Data Coordinating Center(SADaCC)组织,来自 14 个国家的 44 名参与者参加了研讨会,其中 2 名参与者远程参加。值得注意的是,从使科学会议设计民主化和创新的角度来看,一名 SCD 患者倡导者也在研讨会上发言,更广泛地从现实生活的角度介绍了患者的愿望、需求和挑战。研讨会的一个主要内容是利用 SCDO 来协调不同研究使用的数据元素的新方法。这是通过一个基于网络的平台来实现的,参与者在研讨会之前将之前或正在进行的与 SCD 相关的研究的数据元素上传到该平台上,从而使基于现有 SCD 数据的多站点合作研究成为可能,包括多站点队列、SCD 全球临床试验和 SCD 社区参与方法。学员们提出了在关键 SCD 研究领域进行系统文献综述的提案。本专家综述强调了 SCDO 启用的数据标准和协调的潜力和前景,以促进大规模的全球 SCD 合作计划。随着公共卫生和全球卫生领域继续向行星健康领域扩展,SCDO 有望在进一步阐明 SCD 病理生理学以及共同设计该领域的诊断和治疗创新方面发挥突出作用。